The legalisation of marijuana is currently the topic of intense debate in the United States, with the debate centring on whether or not the drug should be legalised for recreational use.
The legal status of marijuana has been a controversial issue for years, with states having to decide on their own whether to legalise the drug.
Currently, there are more than a dozen states that have legalised marijuana, including Colorado, Washington, Oregon and Alaska.
There are currently more than 50 states that still have some sort of legalisation status.
However, states have to determine whether or when to legalize the drug, meaning that some states will be more likely to legalises cannabis.
If there are fewer than 50 remaining states, states will need to look at which ones they can legalize.
The current situation in the state of Colorado has caused a rift between state politicians, who have been opposed to legalising marijuana, and medical cannabis patients, who are concerned that the state is putting their health and lives at risk by legalizing the drug for recreational purposes.
In January 2017, the state legislature passed a bill which legalised recreational cannabis use in Colorado.
But the new law only allows recreational use for people aged 21 and over, and not people with medical conditions.
In October 2018, the US House of Representatives voted to remove cannabis from Schedule I of the Controlled Substances Act, which is classified as a drug with no medical use.
That means it cannot be prescribed for medicinal use.
But states still have to decide if or when they want to legalised cannabis, and what form of legal cannabis they want.
The most commonly used forms of legalised pot are marijuana concentrates and oils, which are legal in many US states.
Marijuana concentrates can contain up to 10 per cent THC (tetrahydrocannabinol), the main psychoactive component in marijuana, while oils contain between 50 per cent and 80 per cent CBD (cannabidiol).
However, medical cannabis is often prescribed to people with severe or chronic illnesses, such as Crohn’s disease or HIV.
These patients require a much higher dosage of THC to achieve a similar level of effects in the body.
According to the US National Institute on Drug Abuse, there were more than 12.6 million adults and children in the country who have HIV in 2015.
According the CDC, about 6.4 million Americans aged 18 and older are currently receiving medical cannabis from their doctor.
This number will grow as more people begin using the drug as part of a treatment plan.
Medical marijuana has received much support in the past, with studies finding that cannabis can be helpful for people with Crohn s disease and AIDS.
Medical cannabis can also be used to treat people suffering from multiple sclerosis, PTSD and chronic pain.
There is also a growing trend towards medicinal cannabis for children, as a form of treatment for ADHD and anxiety.
Medical Cannabis patients often feel that their use of medical cannabis can provide relief from their illnesses and help relieve some of their social and physical difficulties, such in the form of social anxiety and depression.
But some experts believe that medicinal cannabis is not a suitable option for those with severe illnesses or who suffer from chronic pain, and that there is currently no evidence to support that it is beneficial for chronic pain patients.
In April 2018, Colorado and Washington became the first US states to legalisation medical marijuana.
The bill passed both houses of the state’s legislature and was signed into law on 25 April 2018.
The state’s recreational cannabis law will officially go into effect on 2 July 2018, and the first patients to start using cannabis for recreational uses will be allowed to do so.
Currently there are a total of 18 states that allow medicinal cannabis.
The remaining states that do not have legalisation are Alabama, Arizona, California, Colorado, Florida, Georgia, Illinois, Kentucky, Louisiana, Massachusetts, Michigan, Mississippi, Montana, Nevada, New Hampshire, New Jersey, New Mexico, North Carolina, Ohio, Oklahoma, Oregon, Pennsylvania, South Carolina, Tennessee, Texas, Utah and Vermont.
The United Kingdom is also considering legalising medical cannabis, as is Uruguay.
There were five medical cannabis states in the world, and Uruguay is the only one that has legalised medicinal cannabis as a treatment option.
In 2018, Uruguay became the most populous country in the Americas to legalize medical cannabis.
According an international survey, 75 per cent of Uruguayans believe cannabis should be available for medical purposes.
The survey also revealed that 73 per cent respondents support the use of cannabis in combination with psychotherapy and medication to treat severe and chronic illness.
Uruguay has also recently been granted the first licence to grow cannabis in the USA, following a long legal battle.
The licence was granted in 2018 and is expected to be up and running by 2021.
Uruguay currently has the highest rate of cannabis consumption in the region, with almost 10,000 people smoking the drug annually.
The number of cannabis users in Uruguay has been increasing at an average rate
